
Tergus and MedPharm are merging to become the premier global end-to-end CDMO for topical and transepithelial drug products! Combined business will take the MedPharm name with Michael Kane, previously Tergus CEO, appointed as new CEO of the merged company. hubs.la/Q02Fz_rm0

English


















